Medicare Enrolled

Dr. Nathan Saint-Amand, M.D.

Allergy & Immunology · New York, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
121 E 60TH ST, New York, NY 10022
2127584633
In practice since 2006 (19 years)
NPI: 1861570830 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Saint-Amand from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Saint-Amand? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Saint-Amand

Dr. Nathan Saint-Amand is an allergy & immunology specialist in New York, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Saint-Amand performed 1,456 Medicare services across 65 unique beneficiaries.

Between the years covered by Open Payments, Dr. Saint-Amand received a total of $1,433 from 17 pharmaceutical and/or device companies across 66 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in allergy & immunology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Saint-Amand is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 1,456 Medicare services $1,433 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,456
Medicare services
Bottom 46% in NY for allergy & immunology
65
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~77 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Allergy immunotherapy preparation
A professional service involving the preparation and administration of one or more antigens.
997 $14 $20
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
235 $20 $75
Allergy injection therapy, multiple injections
A professional service involving the administration of multiple allergen injections.
224 $11 $60
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2022 ↗
$1,433
Total received (2018-2022)
Avg $287/year across 5 years
Bottom 46% in NY for allergy & immunology
17
Companies
66
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,433 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2022
$76
2021
$313
2020
$328
2019
$303
2018
$413

Payments by company (2022)

Consulting
Speaking
Meals & Travel
Research
Teva Pharmaceuticals USA, Inc.
$30
Pharming Healthcare, Inc.
$28
GlaxoSmithKline, LLC.
$18
Top 3 companies account for 100.0% of 2022 payments
All-time payments by company (2018-2022) ›
AstraZeneca Pharmaceuticals LP
$307
Greer Laboratories, Inc.
$236
GlaxoSmithKline, LLC.
$184
Novartis Pharmaceuticals Corporation
$184
ALK-Abello, Inc
$84
Regeneron Healthcare Solutions, Inc.
$71
AIMMUNE THERAPEUTICS, INC.
$62
Teva Pharmaceuticals USA, Inc.
$56
GENZYME CORPORATION
$48
SANOFI-AVENTIS U.S. LLC
$39
PFIZER INC.
$32
Genentech USA, Inc.
$29
Pharming Healthcare, Inc.
$28
Sunovion Pharmaceuticals Inc.
$20
Optinose US, Inc.
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$17
Takeda Pharmaceuticals U.S.A., Inc.
$17
Top 3 companies account for 50.7% of all-time payments
Associated products mentioned in payments ›
AirDuo Digihaler · DUPIXENT · FASENRA · HYQVIA · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ORALAIR · Odactra · PALFORZIA · RUCONEST · SPIRIVA RESPIMAT · TRELEGY ELLIPTA · UTIBRON · XOLAIR · Xhance · Xolair
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an allergy & immunology specialist in New York?
Compare allergy & immunologists in the New York area by procedure volume, costs, and industry payment transparency.
Browse allergy & immunologists nearby

Geographic Context

Allergy & immunologists within 10 mi
214
Per 100K population
13.1
County median income
$104,553
Nearest hospital
NEW YORK-PRESBYTERIAN HOSPITAL
0.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2022
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Saint-Amand is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Saint-Amand experienced with allergy immunotherapy preparation?
Based on Medicare claims data, Dr. Saint-Amand performed 997 allergy immunotherapy preparation services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Saint-Amand receive payments from pharmaceutical companies?
Yes. Dr. Saint-Amand received a total of $1,433 from 17 companies across 66 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Saint-Amand's costs compare to other allergy & immunologists in New York?
Dr. Saint-Amand's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Saint-Amand) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →